207_Combined course Presentations

Neoadjuvant therapy

We advice neoadjuvant therapy in:

• Locally advanced breast cancer

• Breast cancer with predictive factors of response to neoadjuvant chemotherapy or targeted therapy (triple negative or HER2 positive BC)

13